Yangtze Medicine

Volume 5, Issue 2 (June 2021)

ISSN Print: 2475-7330   ISSN Online: 2475-7349

Google-based Impact Factor: 0.31  Citations  

Bioinformatics Analysis Revealed Potential Tumor Suppressors (KLF4/CGN), Oncogenes (SHH/LIF) and Biomarkers of Asian Stomach Adenocarcinoma

HTML  XML Download Download as PDF (Size: 8948KB)  PP. 141-156  
DOI: 10.4236/ym.2021.52015    468 Downloads   957 Views  Citations

ABSTRACT

Stomach adenocarcinoma (STAD) is the fifth most prevalent cancer and the third leading cause of cancer-related death in the world and is more common in Asia than in most Western countries. There is an urgent need to identify potential novel oncogenes and tumor suppressor genes, and biomarkers for STAD. 6652 differentially expressed genes were identified between STAD and normal samples based on the transcriptome data analysis of the TCGA and GEO databases. 13 key modules were identified in STAD by WGCNA analysis. 293 potential STAD associated genes were identified from intersection by Venn Diagram. The 293 intersected genes were enriched in cell cortex and infection by GO and KEGG analysis. 10 hub genes were identified from PPI and Cytoscape analyses of the intersected genes. KLF4/CGN low and SHH/LIF high expression were associated with short overall survival of Asian STAD patients. Bioinformatics analysis revealed potential novel tumor suppressors (KLF4/CGN), oncogenes (SHH/LIF) and biomarkers for diagnosis, therapy and prognosis of STAD, specifically for Asian patients.

Share and Cite:

Zhou, Y. , Wang, Y. , Cheng, J. , Zhang, Y. , Cai, W. , Han, Z. , Wang, M. , Huang, Q. , Peng, X. and Xin, H. (2021) Bioinformatics Analysis Revealed Potential Tumor Suppressors (KLF4/CGN), Oncogenes (SHH/LIF) and Biomarkers of Asian Stomach Adenocarcinoma. Yangtze Medicine, 5, 141-156. doi: 10.4236/ym.2021.52015.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.